[ad_1]
Before they called it ‘Bancovid’. When Health Secretary Abdul Mannan proposed changing the name to ‘Bangavax’, it was accepted by the Chairman of Globe Pharmaceuticals. Harunur Rashid.
The new coronavirus vaccine developed by Globe Biotech, a subsidiary of Globe Pharmaceuticals, has yet to be tested.
Health Secretary Mannan visited Globe Biotech’s office in Dhaka’s Tejgaon on Tuesday to learn about the progress of the vaccine.
“It’s like hearing the name of Bancovid,” he told reporters after speaking with Globe officials.
“I am celebrating the centenary of the birth of the father of the nation. Country means Bangabandhu. Bengal is in your name. Therefore, I have proposed to change the name to Bangavax. It’s like being acceptable to everyone. It represents the Father of the Bangabandhu Nation, Bangladesh and the vaccine. “
Globe President Harunur Rashid said: “When I announced this ticker, I said I would dedicate it to Bangabandhu.”
The Director General of the Department of Health, Prof ABM Khurshid Alam, and the Director General of the Department of Administration of Medicine, Major General Mahbubur Rahman were present with the Secretary of the Department of Health Services during the visit.
They met with senior officials, including the president of Globe Biotech.
Globe Biotech is the only Bangladeshi company in the race to develop vaccines in the coronavirus epidemic.
The World Health Organization is monitoring vaccines that are being developed around the world. The World Health Organization has a list of 42 vaccines in the clinical trial stage and another list of 157 vaccines in the preclinical trial stage (preclinical trial). That list includes Globe Biotech’s Ticker.
Mannan said the government wants to use vaccines made by national companies to fight the coronavirus. That is why the government wants to help advance the vaccine. That is why they have come to visit the institution.
He said that the vaccine that Bangladesh will receive from the World Health Organization and India will not be able to be administered to the entire population of the country. For this reason, the government is also considering the issue of collecting vaccines from domestic sources.
“We have around 160 million people. Therefore, I will not be able to bring all the vaccines from abroad. At some point we have to make arrangements for production in the country. In this case, we have to see if they show up. If the vaccine can be produced, the name of Bangladesh will shine in the world. “
ABM Khurshid Alam, Director General of the Department of Health, said that the Department of Health is ready to extend all possible cooperation to carry forward the work of experimental application of Globe Biotech vaccine.
Major General Mahbubur Rahman, director general of the Department of Drug Administration, said that any vaccine must comply with the experimental initiation protocol.
“Globe Biotech has conducted an animal test on this ticker. Our approval must be obtained at each stage for the first, second and third trials. If all goes well, we will help at each stage as soon as possible ”.
At the same time, he said, “But there will be no compromise on safety, efficiency and quality. We will adhere to this strictly. You cannot say how long it will take. But it will take one to a year and a half.”
At a press conference held at Globe Pharmaceuticals headquarters in Tejgaon on July 3, Globe Biotech announced its efforts to develop a coronavirus vaccine.
Later, in a press conference on October 10, the organization said that its possible vaccine has been shown to be “effective and completely safe” when applied to rats.
Globe Biotech also said that they will soon apply to the Bangladesh Medical Research Council (BMRC) for a clinical trial of the potential ‘Bancovid’ vaccine.
Meanwhile, the Memorandum of Understanding (MoU) signed between the ICDDR and the BIR a month and a half ago for the experimental application of the vaccine has been canceled.
Harunur Rashid, president of Globe Pharmaceuticals, announced the cancellation of the contract on Tuesday and said the ICDDR had made the decision after seeing Bir’s reluctance.
[ad_2]
